The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells
SUPPLEMENTARY FIGURES Supplementary Figure 1: Regulation of TALNEC2 by E2F. U2OS cells expressing ER-E2F1 were left untreated or incubated
with OHT (100 nM) for 24 h, then cells were treated or not with 10 μg/mL cycloheximide (CHX) for 8 h. RNA was extracted and TALNEC2 RNA levels were determined by real-time RT-PCR and normalized to GAPDH levels. Real-time PCR experiments were performed in triplicates (A). Schematic representation of the TALNEC2 promoter. The E2F-binding sites are represented as 8-mer nucleotide sequences. The transcription start site (+1) is indicated by an arrow. Schematic representation of human chromosome 2 at the TALNEC2 locus. MCF-7 Chip-seq published data from UCSC Genome Browser ENCODE transcription factor binding tracks is presented (HA-E2F1 antibodies were used) (B). levels for TALNEC2 normal adult and normal fetal tissues. These data were obtained from a prior study of long non-coding RNAs available through the Gene Expression Omnibus archive (GEO, GSE28866, April 2, 2016). Expression for TALNEC2 (ID: "uc002ukz.1") was identified by mapping the hg18 coordinates provided in the GEO dataset (chr2:177202809-177202992-) to GRCh38/h38 coordinates (chr2:176629835-176630018-) using the UCSC Genome Browser LiftOver tool (last accessed April 2, 2016). This region overlays the TALNEC2 region (chr2: 176629589-176637931-; GRCh38.p5) according to ensemble (http://useast.ensembl.org/Homo_sapiens/Gene/Su mmary?db=core;g=ENSG00000163364, last accessed April 2, 2016).
Supplementary Figure 3:
TALNEC2 is a cytosolic lncRNA that regulates cell cycle progression. RNA was extracted from nucleus and cytoplasmic fractions of the MCF-7 (A) and H1299 (B) cells and the levels of nuclear control transcript (MALAT1), cytoplasmic control transcript (GAPDH or Tubulin), and TALNEC2 were determined by Real-time PCR in nuclear and cytoplasmic fractions and normalized to levels of external RNA. Graph presented as fraction of subcellular enrichment out of whole cell levels. Realtime PCR experiments were performed in triplicate (A, B). siRNA (Con siRNA, 100nM) or siRNAs directed against TALNEC2 (siRNA1 (25nM), siRNA2 (100nM)). Next, cells were incubated with hydroxyurea (2mM) for 18 hours. 72 hours post transfection cells were harvested or allowed to resume growth by fresh media wash and growth in the fresh media for times indicated. RNA was extracted and TALNEC2 RNA levels were determined by real-time PCR and normalized to GAPDH levels. Real-time PCR experiments were performed in triplicates (A). Cells were analyzed by FACS using propidium-iodide (PI) protocol. Percentages of cells in G1, S, and G2-M cell-cycle phases are depicted (B). H1299 cells were transfected with either a nonspecific siRNA (Con siRNA, 100nM) or siRNAs directed against TALNEC2 (siRNA1 (25nM), Next, cells were incubated with hydroxyurea (2mM) for 18 hours. 72 hours post transfection cells were harvested or allowed to resume growth by fresh media wash and growth in the fresh media for times indicated. RNA was extracted and TALNEC2 RNA levels were determined by real-time PCR and normalized to GAPDH levels. Real-time PCR experiments were performed in triplicates (C).
